Company News · Jinjiang
Jinjiang Mayor Wang Xiaoyang Leads Official Delegation to LUMIRABIO for On-Site Visit and Strategic Exchange
The municipal delegation heard LUMIRABIO Chairman Cai Jinmiao present the company's end-to-end development and scale-up pathway, facilities and purification systems being developed in line with relevant GMP requirements, and plans for a future lights-out smart factory.
- Published
- Updated
- By
- LUMIRABIO Editorial Team
- Reading time
- 5 min read

Key takeaways
- Jinjiang Mayor Wang Xiaoyang led a municipal delegation to LUMIRABIO on 24 August 2026; Vice Mayors Wu Jingyu and Chen Jinfu joined the visit.
- LUMIRABIO Chairman Cai Jinmiao introduced the company's technology development, biomanufacturing scale-up, and longer-term roadmap in Jinjiang.
- The briefing covered the development arc from lab-scale exploration and pilot validation to process scale-up and industrialization, facilities and purification systems being developed in line with relevant GMP requirements, and a future lights-out biofactory blueprint.
- The discussion connected the 'Jinjiang Experience' with local industrial collaboration and new quality productive forces in biomanufacturing.
- Planning displays and company photographs document the visit but do not prove certification, capacity, regulatory status, or product quality.
An on-site visit and strategic exchange in Jinjiang
On 24 August 2026, Wang Xiaoyang, Mayor of Jinjiang, led a municipal delegation to Fujian Lumira Biotech Co., Ltd.
(LUMIRABIO) for an on-site visit and strategic exchange.
Vice Mayors Wu Jingyu and Chen Jinfu, along with other municipal representatives, participated in the visit.
LUMIRABIO Chairman Cai Jinmiao and the company team welcomed the delegation and delivered a detailed briefing on the company's technology development, biomanufacturing scale-up, and long-term roadmap in Jinjiang.
Scaling synthetic biology: From process development to lights-out biomanufacturing
At the company's strategic planning display, Cai outlined LUMIRABIO's technology and industrialization pathway centered on synthetic biology.
The briefing covered the development arc from lab-scale exploration and pilot-scale process validation to process scale-up and industrialization, supported by facilities and purification systems being developed in line with relevant GMP requirements.
Cai also presented the company's modular smart-production planning and forward-looking blueprint for a future lights-out biofactory.
The briefing emphasized that the challenge in biomanufacturing lies not only in laboratory discovery, but also in achieving stability and efficiency during process scale-up.
LUMIRABIO is advancing the integration of front-end technology development, process optimization, and downstream smart-production planning into a coordinated pathway, translating strategic vision into practical engineering milestones in Jinjiang.


Carrying the 'Jinjiang Experience' forward: Bridging industrial strengths with biotech innovation
The sustainable growth of a biotechnology enterprise relies on internal dedication to scientific rigor, quality, and regulatory compliance, paired with a robust local manufacturing ecosystem.
During the exchange, the municipal delegation and LUMIRABIO's management explored how Jinjiang's dynamic private economy and deep industrial roots can help carry the 'Jinjiang Experience' forward.
The discussion considered how the agility of the county-level economy and the resilience of local supply chains can support stronger connections between scientific innovation and industrial-scale manufacturing, thereby cultivating new quality productive forces in the biopharmaceutical sector.
The exchange remained pragmatic and grounded, focusing on tangible next steps: advancing core processes, maintaining strong quality and compliance standards, and establishing synergies with local industrial resources.
Deeply rooted in Jinjiang: Moving forward with long-term purpose
For LUMIRABIO, being rooted in Jinjiang represents a long-term commitment to real-economy innovation.
Looking ahead, the company will continue executing its strategic priorities: strengthening R&D capabilities, adhering to quality and compliance requirements, and building collaborative bridges across industry, academia, and talent networks.
LUMIRABIO extends its sincere appreciation to Mayor Wang Xiaoyang and the municipal delegation for the visit and open exchange.
With a continued focus on real-world manufacturing and technological innovation, LUMIRABIO remains committed to contributing to high-quality growth in Jinjiang's life-sciences and biopharmaceutical ecosystem.
Next decision
Learn more about LUMIRABIO's company and operating boundaries.
Review the company overview, quality approach, and project-specific inquiry path for qualified B2B collaboration.



